HomeTagsPharmaceutical

pharmaceutical

SGX-LISTED COMPANIES

Top Glove Achieves Major Operational & Financial Turnaround In FY2026

Turnaround Story Top Glove Corporation Bhd has staged a major operational and financial recovery in...
Logistics

DHL invests US$15m in Singapore pharma hub to bolster supply chains

DHL has committed US$15 million to launch its first pharmaceutical logistics facility in Southeast...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...
SGX-LISTED COMPANIES

The Reason The US Department Of War Awarded iX Biopharma A $41M Contract For A Painkiller

Beyond the Needle and the Pill The opioid epidemic remains one of the most significant...
SGX-LISTED COMPANIES

How Vietnam Is Negatively Impacting Hyphens Pharma’s Growth

The Southeast Asian Pharmaceutical Puzzle Navigating the healthcare landscape in Southeast Asia is often described...
SGX-LISTED COMPANIES

Tianjin Pharmaceutical Da Ren Tang Is Shrinking To Succeed In FY2025

How TJ DRT’s 33% Revenue "Loss" Fueled a 72% Margin Miracle and a Record...
SGX-LISTED COMPANIES

Why China Medical Systems FY2025 Profits Dropped Despite Growth

https://open.spotify.com/episode/3YAldvdzS4eXE4RzkN9M18?si=8a54594510534cfe 5 Game-Changing Takeaways from CMS’s 2025 Transformation For the Chinese pharmaceutical sector, 2025 was the...
SGX-LISTED COMPANIES

iX Biopharma’s Secret Shortcut To The US Medical Market – 1H FY2026

From Cash Burn to Bioavailability: How iX Biopharma Slashed Losses by 67% via a...
SGX-LISTED COMPANIES

Why This Tiny Lab Is Outpacing Global Giants

The $1.5 Trillion Green Transition’s Secret Weapon In the high-stakes theater of the modern economy,...
SGX-LISTED COMPANIES

The Secret To Lonza’s Massive FY2025 Growth

5 Key Takeaways from Lonza's Blockbuster 2025 Report Takeaway 1: Record-Breaking Growth That Beat Expectations The...
Load more
spot_img

Latest articles

SGX-LISTED COMPANIES

Lion Asiapac Stays Profitable In Q1 2026 But Core Segment Challenges Lurk Beneath Surface

Lion Asiapac Q1 2026 Results Reveal Hidden Strengths and Clear Red Flags for Investors Investors...
SGX-LISTED COMPANIES

Miyoshi Limited Cuts FY2026 Net Losses By Half But Liquidity Risks Loom Large

Shrinking Losses Amid Operational Shift and Liquidity Hurdles Miyoshi Limited has officially released its full-year...
AI

NusaVest targets US$2B ABSs to ease digital economy funding squeeze

NusaVest is aiming to facilitate at least US$2 billion in asset-backed securities transactions over...
SGX-LISTED COMPANIES

Sheng Siong Group Delivers 3Q FY2026 Growth Amid Inflationary Pressures

Sheng Siong Group Demonstrates Resilience and Expansion Sheng Siong Group Ltd has released its business...